Get started
Author

Atsuhito Tone

Observed names: A. Tone, ATSUHITO TONE, Tone, Atsuhito
Observed institutions: Tokai University, Okayama University, Fukuoka University, Okayama University Hospital, Okayama Red Cross General Hospital, National Hospital Organization, Okayama Saiseikai General Hospital, Okayama Medical Center
ORCID: 0000-0003-4335-1516
Observed ORCID: 0000-0003-4335-1516
OpenAlex ID: A5026503449
Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
2005 · Atsuhito Tone, Kenichi Shikata, et al. · Diabetes Research and Clinical Practice · 142
Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation
2007 · Hitomi Kataoka Usui, Kenichi Shikata, et al. · Diabetes · 92
40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004
2004 · M. Veitenhansl, K. Stegner, et al. · Diabetologia · 70
Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray
2013 · Kentaro Inoue, Jun Wada, et al. · PLoS ONE · 66
PDF
Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis
2020 · Ichiro Nojima, Shingo Eikawa, et al. · Scientific Reports · 61
PDF
Cerebroside Sulfotransferase Deficiency Ameliorates L-selectin-dependent Monocyte Infiltration in the Kidney after Ureteral Obstruction
2004 · Daisuke Ogawa, Kenichi Shikata, et al. · Journal of Biological Chemistry · 41
Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats
2005 · A. Tone, K. Shikata, et al. · Diabetologia · 40
PDF
P-Selectin Glycoprotein Ligand-1 Deficiency Is Protective Against Obesity-Related Insulin Resistance
2010 · Chikage Sato, Kenichi Shikata, et al. · Diabetes · 37
Prevention of hypoglycemia by intermittent-scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: A randomized, crossover trial
2022 · Takashi Murata, Kiminori Hosoda, et al. · Diabetes Research and Clinical Practice · 30
PDF
Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor
2007 · Atsuhito Tone, Kenichi Shikata, et al. · Journal of the Renin-Angiotensin-Aldosterone System · 27
PDF
Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria
2013 · Motonobu Nishimura, Yasuhisa Kato, et al. · Hypertension Research · 23
PDF
Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1
2018 · Koki Mise, Mariko Imamura, et al. · Diabetes Care · 22
Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY)
2020 · Takashi Murata, Akio Kuroda, et al. · Journal of Diabetes Science and Technology · 21
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study
2023 · Naoki Sakane, Yushi Hirota, et al. · Journal of Diabetes Investigation · 19
Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
2010 · A. Tone, I. Iseda, et al. · Experimental and Clinical Endocrinology & Diabetes · 18
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study
2024 · Yoshimi Muta, Kazuo Kobayashi, et al. · Frontiers in Pharmacology · 12
PDF
Computed tomography findings of congenital generalized lipodystrophy: multiple nodular fatty liver and diffuse sclerosis of bones
2007 · Takayoshi Shinya, Shuhei Sato, et al. · Radiation Medicine · 12
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication
2023 · Kazuo Kobayashi, Masao Toyoda, et al. · Diabetes and Vascular Disease Research · 10
The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study
2019 · Akihiro Katayama, Atsuhito Tone, et al. · Diabetology International · 10
A Pregnant Patient with Brittle Type 1 Diabetes Successfully Managed by CSII Therapy with Insulin Aspart
2010 · Chigusa Higuchi, Atsuhito Tone, et al. · Journal of Diabetes & Metabolism · 10
PDF
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide ‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
2024 · RECAP study group, Shunichiro Tsukamoto, et al. · Diabetes Obesity and Metabolism · 9
PDF
Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2)
2021 · Koki Mise, Mariko Imamura, et al. · Frontiers in Cardiovascular Medicine · 9
PDF
Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale
2019 · Naoki Sakane, Takashi Murata, et al. · Diabetes Technology & Therapeutics · 9
Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)
2024 · Asami Ueno, Yasuhiro Onishi, et al. · BMJ Open Diabetes Research & Care · 8
Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus
2023 · Naoki Sakane, Yushi Hirota, et al. · Diabetology International · 8
PDF
Works count: 68
Citation count: 886
H-index: 15
I10-index: 19
Year
Topic
Type